Targeting mitochondrial ion channels for cancer therapy

Pharmacological targeting of mitochondrial ion channels is emerging as a promising approach to eliminate cancer cells; as most of these channels are differentially expressed and/or regulated in cancer cells in comparison to healthy ones, this strategy may selectively eliminate the former. Perturbati...

Full description

Bibliographic Details
Main Authors: Ildiko Szabo, Mario Zoratti, Lucia Biasutto
Format: Article
Language:English
Published: Elsevier 2021-06-01
Series:Redox Biology
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S221323172031051X
id doaj-5ec3b95f5f1a4baea7e050b37af05854
record_format Article
spelling doaj-5ec3b95f5f1a4baea7e050b37af058542021-04-26T05:55:30ZengElsevierRedox Biology2213-23172021-06-0142101846Targeting mitochondrial ion channels for cancer therapyIldiko Szabo0Mario Zoratti1Lucia Biasutto2Department of Biology, University of Padova, Italy; CNR Institute of Neurosciences, Padova, Italy; Corresponding author. viale G. Colombo 3, 35121, Padova, Italy.CNR Institute of Neurosciences, Padova, ItalyCNR Institute of Neurosciences, Padova, Italy; Department of Biomedical Sciences, University of Padova, ItalyPharmacological targeting of mitochondrial ion channels is emerging as a promising approach to eliminate cancer cells; as most of these channels are differentially expressed and/or regulated in cancer cells in comparison to healthy ones, this strategy may selectively eliminate the former. Perturbation of ion fluxes across the outer and inner membranes is linked to alterations of redox state, membrane potential and bioenergetic efficiency. This leads to indirect modulation of oxidative phosphorylation, which is/may be fundamental for both cancer and cancer stem cell survival. Furthermore, given the crucial contribution of mitochondria to intrinsic apoptosis, modulation of their ion channels leading to cytochrome c release may be of great advantage in case of resistance to drugs triggering apoptotic events upstream of the mitochondrial phase. In the present review, we give an overview of the known mitochondrial ion channels and of their modulators capable of killing cancer cells. In addition, we discuss state-of-the-art strategies using mitochondriotropic drugs or peptide-based approaches allowing a more efficient and selective targeting of mitochondrial ion channel-linked events.http://www.sciencedirect.com/science/article/pii/S221323172031051XMitochondriaIon channelsCancerDrug targetingChannel interactions
collection DOAJ
language English
format Article
sources DOAJ
author Ildiko Szabo
Mario Zoratti
Lucia Biasutto
spellingShingle Ildiko Szabo
Mario Zoratti
Lucia Biasutto
Targeting mitochondrial ion channels for cancer therapy
Redox Biology
Mitochondria
Ion channels
Cancer
Drug targeting
Channel interactions
author_facet Ildiko Szabo
Mario Zoratti
Lucia Biasutto
author_sort Ildiko Szabo
title Targeting mitochondrial ion channels for cancer therapy
title_short Targeting mitochondrial ion channels for cancer therapy
title_full Targeting mitochondrial ion channels for cancer therapy
title_fullStr Targeting mitochondrial ion channels for cancer therapy
title_full_unstemmed Targeting mitochondrial ion channels for cancer therapy
title_sort targeting mitochondrial ion channels for cancer therapy
publisher Elsevier
series Redox Biology
issn 2213-2317
publishDate 2021-06-01
description Pharmacological targeting of mitochondrial ion channels is emerging as a promising approach to eliminate cancer cells; as most of these channels are differentially expressed and/or regulated in cancer cells in comparison to healthy ones, this strategy may selectively eliminate the former. Perturbation of ion fluxes across the outer and inner membranes is linked to alterations of redox state, membrane potential and bioenergetic efficiency. This leads to indirect modulation of oxidative phosphorylation, which is/may be fundamental for both cancer and cancer stem cell survival. Furthermore, given the crucial contribution of mitochondria to intrinsic apoptosis, modulation of their ion channels leading to cytochrome c release may be of great advantage in case of resistance to drugs triggering apoptotic events upstream of the mitochondrial phase. In the present review, we give an overview of the known mitochondrial ion channels and of their modulators capable of killing cancer cells. In addition, we discuss state-of-the-art strategies using mitochondriotropic drugs or peptide-based approaches allowing a more efficient and selective targeting of mitochondrial ion channel-linked events.
topic Mitochondria
Ion channels
Cancer
Drug targeting
Channel interactions
url http://www.sciencedirect.com/science/article/pii/S221323172031051X
work_keys_str_mv AT ildikoszabo targetingmitochondrialionchannelsforcancertherapy
AT mariozoratti targetingmitochondrialionchannelsforcancertherapy
AT luciabiasutto targetingmitochondrialionchannelsforcancertherapy
_version_ 1721507931617230848